These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 26085010)

  • 1. Mannan-modified adenovirus targeting TERT and VEGFR-2: A universal tumour vaccine.
    Wang Y; Zhang J; Wu Y; Ding ZY; Luo XM; Liu J; Zhong WN; Deng GH; Xia XY; Deng YT; Wei YQ; Jiang Y
    Sci Rep; 2015 Jun; 5():11275. PubMed ID: 26085010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mannan-modified adenovirus encoding VEGFR-2 as a vaccine to induce anti-tumor immunity.
    Zhang J; Wang Y; Wu Y; Ding ZY; Luo XM; Zhong WN; Liu J; Xia XY; Deng GH; Deng YT; Wei YQ; Jiang Y
    J Cancer Res Clin Oncol; 2014 May; 140(5):701-12. PubMed ID: 24525706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumour immunity mediated by mannan-modified adenovirus vectors expressing VE-cadherin.
    Zhao Z; Yao Y; Ding Z; Chen X; Xie K; Luo Y; Zhang J; Chen X; Wu X; Xu J; Zhao J; Niu T; Liu J; Li Q; Zhang W; Wen Y; Su J; Hu B; Bu H; Wei Y; Wu Y
    Vaccine; 2011 Jun; 29(25):4218-24. PubMed ID: 21497630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
    Pan JP; Weng YS; Wu QQ
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mannan-modified adenovirus as a vaccine to induce antitumor immunity.
    Ding ZY; Wu Y; Luo Y; Su JM; Li Q; Zhang XW; Liu JY; He QM; Yang L; Tian L; Zhao X; Deng HX; Wen YJ; Li J; Kang B; Wei YQ
    Gene Ther; 2007 Apr; 14(8):657-63. PubMed ID: 17287861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A novel strategy for development of universal tumor vaccine: a DC-targeted adenovirus encoding hTRT].
    Ding ZY; Wang C; Su JM; Wei YQ; Wang CT
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):369-73. PubMed ID: 19626983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination of fiber-modified adenovirus-transfected dendritic cells to express HER-2/neu stimulates efficient HER-2/neu-specific humoral and CTL responses and reduces breast carcinogenesis in transgenic mice.
    Sas S; Chan T; Sami A; El-Gayed A; Xiang J
    Cancer Gene Ther; 2008 Oct; 15(10):655-66. PubMed ID: 18421311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of anti-tumour immunity by dendritic cells transduced with hTERT recombinant adenovirus in mice.
    Chen L; Tang XD; Yu ST; Ai ZH; Fang DC; Cai YG; Luo YH; Liang GP; Yang SM
    J Pathol; 2009 Apr; 217(5):685-92. PubMed ID: 19142972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of expression vector of hTERT- hIL18 fusion gene and induction of cytotoxic T lymphocyte response against hTERT.
    Tong XM; Zheng SE; Bader A; Yao HP; Wu NP; Altmeyer P; Brockmeyer NH; Jin J
    Eur J Med Res; 2008 Jan; 13(1):7-14. PubMed ID: 18226991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Truncated TERT mRNA transfected dendritic cells evoke TERT specific antitumor response in vivo.
    Qiu J; Lil GW; Sui YF; Sun YJ; Huang YY; Si SY; Ge W; Song HP
    Hepatogastroenterology; 2007; 54(75):681-7. PubMed ID: 17591041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells.
    Okada N; Saito T; Masunaga Y; Tsukada Y; Nakagawa S; Mizuguchi H; Mori K; Okada Y; Fujita T; Hayakawa T; Mayumi T; Yamamoto A
    Cancer Res; 2001 Nov; 61(21):7913-9. PubMed ID: 11691812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunity against tumor angiogenesis induced by a fusion vaccine with murine beta-defensin 2 and mFlk-1.
    Wang YS; Wang GQ; Wen YJ; Wang L; Chen XC; Chen P; Kan B; Li J; Huang C; Lu Y; Zhou Q; Xu N; Li D; Fan LY; Yi T; Wu HB; Wei YQ
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6779-87. PubMed ID: 18006780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
    Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
    Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergy between tumor immunotherapy and antiangiogenic therapy.
    Nair S; Boczkowski D; Moeller B; Dewhirst M; Vieweg J; Gilboa E
    Blood; 2003 Aug; 102(3):964-71. PubMed ID: 12689940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy of tumors with human telomerase reverse transcriptase immortalized human umbilical vein endothelial cells.
    Mu X; Sang Y; Fang C; Shao B; Yang L; Yao K; Zhao X; Gou J; Wei Y; Yi T; Wu Y; Zhao X
    Int J Oncol; 2015 Nov; 47(5):1901-11. PubMed ID: 26398907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Oncolytic Adenovirus Targeting Transforming Growth Factor β Inhibits Protumorigenic Signals and Produces Immune Activation: A Novel Approach to Enhance Anti-PD-1 and Anti-CTLA-4 Therapy.
    Yang Y; Xu W; Peng D; Wang H; Zhang X; Wang H; Xiao F; Zhu Y; Ji Y; Gulukota K; Helseth DL; Mangold KA; Sullivan M; Kaul K; Wang E; Prabhakar BS; Li J; Wu X; Wang L; Seth P
    Hum Gene Ther; 2019 Sep; 30(9):1117-1132. PubMed ID: 31126191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
    Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
    Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.
    Xia D; Moyana T; Xiang J
    Cell Res; 2006 Mar; 16(3):241-59. PubMed ID: 16541123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combination of NK and CD8+T cells with CCL20/IL15-armed oncolytic adenoviruses enhances the growth suppression of TERT-positive tumor cells.
    Ye JF; Qi WX; Liu MY; Li Y
    Cell Immunol; 2017 Aug; 318():35-41. PubMed ID: 28651743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.